PRCTNasdaq

PROCEPT BioRobotics Corporation

Healthcare·Oncology·Commercial·San Jose, CA, United States
OncologyReproductive

PROCEPT BioRobotics Corporation (PRCT): 3 pipeline candidates · ~24 mo cash runway · 3 clinical trials. Updated within the last hour.

8.4/10

BioSniper Score

5-factor signal · derived from public data

Cash Runway6.6

23.8 months

Financial Health9.4

D/E 0.40 · 0% dilution

Pipeline Maturity10.0

Lead: Approved

Pipeline Breadth5.9

3 candidates

Catalyst MomentumN/A

N/A

Insider Signal9.9

7 buys · 8 sells (180d)

A transparent, data-derived signal for PROCEPT BioRobotics Corporationacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$1.5B

Cash

$248.7M

Quarterly Burn

$38.1M

Runway

23.8 mo

Revenue

$83.1M

Cash Runway vs Catalysts

Tracked catalysts land within the current projected cash runway.

Cash ends ~Jun 2028
Today~26 mo out
Catalyst within runway

Pipeline (3 candidates)

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

255

Total value held

$1.33B

HolderSharesValue
vanguard capital management llc4,798,134$120.0M
blackrock, inc.4,362,002$109.1M
bnp paribas asset management holding s.a.3,089,378$77.3M
vanguard portfolio management llc2,421,362$60.6M
prosight management, lp1,945,000$48.6M
mackenzie financial corp1,720,738$43.0M
state street corp1,529,631$38.3M
fmr llc1,461,904$36.6M
geode capital management, llc1,363,500$34.1M
artisan partners limited partnership1,187,349$29.7M

Showing top 10 of 255 institutional holders of PROCEPT BioRobotics Corporation. Sign up for the full 13F holder list and quarter-by-quarter ownership history.

3 clinical trials·CEO: Mr. Larry L. Wood

Frequently asked questions

How many drug candidates are in PROCEPT BioRobotics Corporation's pipeline?

PROCEPT BioRobotics Corporation (PRCT) has 3 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is PROCEPT BioRobotics Corporation's cash runway?

Based on its most recent reported cash balance and quarterly burn rate, PROCEPT BioRobotics Corporation has approximately 23.8 months of cash runway.

What is PROCEPT BioRobotics Corporation's market capitalization?

PROCEPT BioRobotics Corporation's market capitalization is approximately $1.5B.

Who is the CEO of PROCEPT BioRobotics Corporation?

Mr. Larry L. Wood is the chief executive officer of PROCEPT BioRobotics Corporation (PRCT).

Get the full picture on PROCEPT BioRobotics Corporation

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.